AzTrials
AzTrials

Paraesophageal HerniaPEH3NCT06107634

Gastropexy in the Repair of Patients With Paraesophageal Hernias

A study testing Gastropexy and Paraesophageal hernia repair in people with Paraesophageal Hernia, run by Ersta Diakoni at 6 sites in Sweden.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Patients scheduled for surgery for primary paraesophageal herniation are randomized to either conventional surgical hernia repair or with the addition of gastropexy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Paraesophageal Hernia
What is being tested?
Gastropexy and Paraesophageal hernia repair
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
6 sitesSweden
Study dates
1 Jun 2023to 30 Nov 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients diagnosed with a primary paraesophageal hernia (hiatal hernia types II-IV) who are scheduled for elective or emergency surgical repair at participating centers

Who cannot join

  • Previous major upper gastrointestinal (GI) surgery, including prior hiatal hernia repair.
  • Diagnosis of achalasia or any other significant esophageal motility disorder.
  • Inability to understand the purpose of the study and/or inability or unwillingness to provide informed consent.
  • Severe comorbidities, defined by an American Society of Anesthesiologists (ASA) physical status score of greater than III.

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

Sweden6 sites
  • Sahlgrenska University Hospital

    Gothenburg, 413 45

  • Skåne University Hospital Lund

    Lund, 221 85

  • Nyköping Hospital

    Nyköping, 611 85

  • Ersta Hospital

    Stockholm, 11691

  • Sundsvall County Hospital

    Sundsvall, 856 43

  • Uppsala Academic Hospital

    Uppsala, 751 85

Other trials in Sweden

About this study

Official title: Can Gastropexy Improve the Efficacy of the Crural Repair in Patients With Paraesophageal Hernias? A Double Blind, Randomized, Multicenter Clinical Trial

Patients scheduled for surgery for primary paraesophageal herniation are randomized to either conventional surgical hernia repair or with the addition of gastropexy.

Read the detailed description

Patients scheduled for surgery due to primary paraesophageal herniation are randomized into either the control group or the interventional group.

Control Group: Patients undergo a crural repair combined with a short and floppy Nissen fundoplication.

Interventional Group: In addition to the crural repair and Nissen fundoplication, patients receive a gastropexy. This involves the fixation of the posterior part of the wrap the right crus, the left portion of the wrap to the diaphragm, and the minor curvature of the stomach to the abdominal wall.

Follow-Up Assessments:

Imaging: Computed tomography (CT) scans are performed before surgery and at 1 and 3 years postoperatively to evaluate anatomical outcomes.

Patient-Reported Outcomes: The following questionnaires are completed before surgery, as well as at 3 months, 1 year, and 3 years after surgery:

SF-36: A global quality of life instrument. GSRS: The Gastrointestinal Symptoms Rating Scale. Reflux Frequency Questionnaire: A measure reflux disease-related symptoms. Dakkak's Dysphagia Score: An assessment of swallowing difficulties.

Being tested
Gastropexy, Paraesophageal hernia repair
Medical subject headings
Hernia, Hiatal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GastropexyProcedure or surgery

    In the intervention group, a three-point gastropexy is added to the repair. First, the right fundus flap is adapted posteriorly to the crural portion of the diaphragm with a 2-3 cm long running non-absorbable suture ("posterior gastropexy"). Second, the left fundus flap is adapted to the diaphragm anterolateral to the hiatus with a 2-3 cm long running non-absorbable suture ("left anterolateral gastropexy"). Finally, the minor curvature of the anterior stomach wall is adapted during reduced intraabdominal pressure to the anterior abdominal wall with a 2-3 cm long running non-absorbable suture ("anterior gastropexy").

  • Paraesophageal hernia repairProcedure or surgery

    Ultrasonic shears are used for dissection. The herniated viscera are completely reduced into the abdomen and the hernia sac in fully dissected and resected. The esophagus is mobilized intraabdominally until at least 3 cm rests below the hiatus without tension. The anterior and posterior vagal nerves are identified and preserved. A posterior crural closure with running non-absorbable sutures is performed. An additional anterior crural closure may be performed at the surgeon's discretion. The fundus is mobilized to allow a floppy fundoplication. A total fundoplication is created by three interrupted non-absorbable sutures. No bougies are used routinely for calibration of the fundoplication.

Study groups in NCT06107634
Study groupRoleWhat they receive
Standard paraesophageal hernia repairActive comparatorStandard paraesophageal hernia repair (crural suturing and a total (Nissen) fundoplication)
Receives: Procedure: Paraesophageal hernia repair
Standard paraesophageal hernia repair + gastropexyExperimentalStandard paraesophageal hernia repair with the addition of a three point gastropexy (posterior, left anterolateral and anterior gastropexy)
Receives: Procedure: Gastropexy; Procedure: Paraesophageal hernia repair

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recurrence of hernia at 1 year after surgery

    Computer tomography of abdomen and thorax

    Measured: 1 year

Secondary outcomes (7)
  1. Recurrence of hernia at 3 years after surgery

    Computer tomography of abdomen and thorax

    Measured: 3 year

  2. Complications after surgery

    Complication classified according to Clavien-Dindo

    Measured: 30 days after surgery

  3. Length of stay at the hospital after surgery

    Information from patients journal

    Measured: 30 days after surgery

  4. Changes in the patients perception of quality of life after surgery

    SF-36 (Short Form 36) is a health related quality of life questionnaire. SF-36 is comprised of 36 items that assess eight dimensions of health: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions. Higher scores mean a better outcome. These can be grouped into mental and physical component summary scores. Scoring is from 0-100. A mean score of 50 has been articulated as normative value.

    Measured: 3 months, 12 months, and 36 months

  5. Changes in the patients perception of gastrointestinal symptoms after surgery

    GSRS (The Gastrointestinal Symptom Rating Scale) is a questionnaire, which contains 15 items, and uses a seven-graded Likert scale, where 1 represents the most positive option and 7 the most negative one. The questions are grouped in five dimensions. A mean value for the items in each dimension will be calculated:

    Diarrhoea syndrome: 11. Increased passage of stools 12. Loose stools 14. Urgent need for defecation

    Indigestion syndrome: 6. Borborygmus 7. Abdominal distension 8. Eructation 9. Increased flatus

    Constipation syndrome: 10. Decreased passage of stools 13. Hard stools 15. Feeling of incomplete evacuation

    Abdominal pain syndrome: 1. Abdominal pain 4. Sucking sensations 5. Nausea and vomiting

    Reflux syndrome: 2. Heartburn 3. Acid regurgitation.

    Measured: 3 months, 12 months, and 36 months

  6. Changes in the patients perception of dysphagia after surgery

    The Dakkak dysphagia score is a questionnaire for assessing benign dysphagia, including nine questions regarding the frequency (always, sometimes, or never) of swallowing difficulties with different food consistencies (liquid, semisolid, and solid foods). The final score ranges from 0 to 45, where 45 represents the most severe dysphagia.

    Measured: 3 months, 12 months, and 36 months

  7. Changes in the patients perception of dysphagia and reflux frequency after surgery

    Symptoms of heartburn, reflux, chest pain, dysphagia for liquids and solids, dyspnea, coughing and odynophagia were recorded using a four-graded scale to assess the frequency of symptoms with an arbitrary (empirical) cut off for clinical significance. The same instrument has been used in a previous RCT, from the same institution, comparing different types of anti-reflux procedures.

    Measured: 3 months, 12 months, and 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2023
  2. Study start1 Jun 2023
  3. Primary completion31 Oct 2027 (estimated)
  4. Study completion30 Nov 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Conventional paraesophageal hernia repair with the addition of gastropexy
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06107634
Sponsor's protocol ID
Dnr 2023-01956-01
Acronym
PEH3
Status last verified
Oct 2026
First submitted
19 Sep 2023
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Dackhammar JB, Tsoposidis A, Wallenius V, Kostic S, Cengiz Y, Linder G, Jeremiasen M, Analatos A, Lundell L, Hakanson B, Thorell A, Hansson MR. Can gastropexy reduce the recurrence rate after paraesophageal hernia repair? A study protocol for a double blind, randomized, multicenter clinical trial. Trials. 2026 Mar 16;27(1):281. doi: 10.1186/s13063-026-09578-7.

    PubMed 41840686

Questions about this trial

What is this clinical trial studying?

A study testing Gastropexy and Paraesophageal hernia repair in people with Paraesophageal Hernia, run by Ersta Diakoni at 6 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recurrence of hernia at 1 year after surgery (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06107634, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in